LRRK2 and Parkinson disease: Songsomboon et al. (78) proposed the use of SUA/serum creatinine as a more sensitive diagnostic tool, and Bougea et al. (79) suggested that SUA might be a marker specific for PD patients with a causative LRRK2 mutation.